{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:24:24Z","timestamp":1791901464052,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"39","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["CDMRP RA210290"],"award-info":[{"award-number":["CDMRP RA210290"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["CDMRP RA210290"],"award-info":[{"award-number":["CDMRP RA210290"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["CDMRP RA210290"],"award-info":[{"award-number":["CDMRP RA210290"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS125175-01A1"],"award-info":[{"award-number":["K08NS125175-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K08NS125175-01A1"],"award-info":[{"award-number":["K08NS125175-01A1"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002564","name":"Alternatives Research and Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children's Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cellular Imaging Core Pilot to MU (Imaging Services) Schwartz Family"},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R24GM137786"],"award-info":[{"award-number":["R24GM137786"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R24GM137786"],"award-info":[{"award-number":["R24GM137786"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R24GM137786"],"award-info":[{"award-number":["R24GM137786"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2025,10,14]]},"DOI":"10.1038\/s41388-025-03533-7","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:33:58Z","timestamp":1757183638000},"page":"3694-3712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Multicellular tumor-stromal interactions recapitulate aspects of therapeutic response and human oncogenic signaling in a 3D disease model for H3K27M-altered DIPG"],"prefix":"10.1038","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3727-2410","authenticated-orcid":false,"given":"Meenakshi","family":"Upreti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astgik","family":"Petrosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-2703","authenticated-orcid":false,"given":"Matthew E.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahit","family":"Hovsepyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Esteban","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Koos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Byrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Mackintosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob K.","family":"Al-Husseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Tackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malkiat S.","family":"Johal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Erdreich-Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Margol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan H.","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Asgharzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rex A.","family":"Moats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"key":"3533_CR1","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2017.75.9308","volume":"36","author":"LM Hoffman","year":"2018","unstructured":"Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, et al. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. J Clin Oncol. 2018;36:1963\u201372.","journal-title":"J Clin Oncol"},{"key":"3533_CR2","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1007\/s00381-023-06037-5","volume":"39","author":"U Tosi","year":"2023","unstructured":"Tosi U, Souweidane M. Fifty years of DIPG: looking at the future with hope. Child\u2019s Nerv Syst ChNS. 2023;39:2675\u201386.","journal-title":"Child\u2019s Nerv Syst ChNS"},{"key":"3533_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00401-014-1307-x","volume":"128","author":"V Caretti","year":"2014","unstructured":"Caretti V, Bugiani M, Freret M, Schellen P, Jansen M, van Vuurden D, et al. Subventricular spread of diffuse intrinsic pontine glioma. Acta Neuropathol. 2014;128:605\u20137.","journal-title":"Acta Neuropathol"},{"key":"3533_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.cell.2017.07.016","volume":"170","author":"EY Qin","year":"2017","unstructured":"Qin EY, Cooper DD, Abbott KL, Lennon J, Nagaraja S, Mackay A, et al. Neural Precursor-Derived Pleiotrophin Mediates Subventricular Zone Invasion by Glioma. Cell. 2017;170:845\u2013859.e819.","journal-title":"Cell"},{"key":"3533_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s41016-020-00218-w","volume":"7","author":"D Srikanthan","year":"2021","unstructured":"Srikanthan D, Taccone MS, Van Ommeren R, Ishida J, Krumholtz SL, Rutka JT. Diffuse intrinsic pontine glioma: current insights and future directions. Chinese Neurosurg J. 2021;7:6.","journal-title":"Chinese Neurosurg J"},{"key":"3533_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/ped.14070","volume":"62","author":"A Hayashi","year":"2020","unstructured":"Hayashi A, Ito E, Omura M, Aida N, Tanaka M, Tanaka Y, et al. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma. Pediatrics Int. 2020;62:47\u201351.","journal-title":"Pediatrics Int"},{"key":"3533_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00381-019-04363-1","volume":"36","author":"JS Rechberger","year":"2020","unstructured":"Rechberger JS, Lu VM, Zhang L, Power EA, Daniels DJ. Clinical trials for diffuse intrinsic pontine glioma: the current state of affairs. Child\u2019s Nerv Syst ChNS. 2020;36:39\u201346.","journal-title":"Child\u2019s Nerv Syst ChNS"},{"key":"3533_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11940-019-0577-y","volume":"21","author":"NA Vitanza","year":"2019","unstructured":"Vitanza NA, Monje M. Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials. Curr Treat Options Neurol. 2019;21:37.","journal-title":"Curr Treat Options Neurol"},{"key":"3533_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fonc.2015.00148","volume":"5","author":"A Morales La Madrid","year":"2015","unstructured":"Morales La Madrid A, Hashizume R, Kieran MW. Future Clinical Trials in DIPG: Bringing Epigenetics to the Clinic. Front Oncol. 2015;5:148.","journal-title":"Front Oncol"},{"key":"3533_CR10","first-page":"159","volume":"37","author":"Q Bailleul","year":"2021","unstructured":"Bailleul Q, Rakotomalala A, Ferry I, Leblond P, Meignan S, Furlan A. The art of war as applied to pediatric gliomas: Know your enemy]. Med Sci. 2021;37:159\u201366.","journal-title":"Med Sci"},{"key":"3533_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1349612","volume":"15","author":"C Lin","year":"2024","unstructured":"Lin C, Smith C, Rutka J. Current immunotherapeutic approaches to diffuse intrinsic pontine glioma. Front Genet. 2024;15:1349612.","journal-title":"Front Genet"},{"key":"3533_CR12","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","volume":"603","author":"RG Majzner","year":"2022","unstructured":"Majzner RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM, et al. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas. Nature. 2022;603:934\u201341.","journal-title":"Nature"},{"key":"3533_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT, Kool M, et al. Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell. 2013;24:660\u201372.","journal-title":"Cancer Cell"},{"key":"3533_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW, M\u00fcller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, et al. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science. 2013;340:857\u201361.","journal-title":"Science"},{"key":"3533_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/1570159X14666160509123229","volume":"15","author":"TB Johung","year":"2017","unstructured":"Johung TB, Monje M. Diffuse Intrinsic Pontine Glioma: New Pathophysiological Insights and Emerging Therapeutic Targets. Curr Neuropharmacol. 2017;15:88\u201397.","journal-title":"Curr Neuropharmacol"},{"key":"3533_CR16","doi-asserted-by":"crossref","unstructured":"Chiarelli PA, Chu JK, Krieger MD. Brainstem Tumors. In: Di Rocco C, Pang D, Rutka JT (eds). Textbook of Pediatric Neurosurgery. Springer International Publishing: Cham, 2019, pp 1\u201335.","DOI":"10.1007\/978-3-319-31512-6_89-1"},{"key":"3533_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fonc.2012.00205","volume":"2","author":"KE Warren","year":"2012","unstructured":"Warren KE. Diffuse intrinsic pontine glioma: poised for progress. Front Oncol. 2012;2:205.","journal-title":"Front Oncol"},{"key":"3533_CR18","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s40272-013-0033-5","volume":"15","author":"R Kebudi","year":"2013","unstructured":"Kebudi R, Cakir FB. Management of diffuse pontine gliomas in children: recent developments. Paediatr Drugs. 2013;15:351\u201362.","journal-title":"Paediatr Drugs"},{"key":"3533_CR19","doi-asserted-by":"crossref","unstructured":"Van Gool SW, Makalowski J, Bonner ER, Feyen O, Domogalla MP, Prix L et al. Addition of multimodal immunotherapy to combination treatment strategies for children with DIPG: A single institution experience. Medicines 2020; 7.","DOI":"10.3390\/medicines7050029"},{"key":"3533_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccell.2023.11.002","volume":"42","author":"C Koschmann","year":"2024","unstructured":"Koschmann C, Al-Holou WN, Alonso MM, Anastas J, Bandopadhayay P, Barron T, et al. A road map for the treatment of pediatric diffuse midline glioma. Cancer Cell. 2024;42:1\u20135.","journal-title":"Cancer Cell"},{"key":"3533_CR21","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/bs.mie.2019.05.023","volume":"632","author":"MB Garcia-Fabiani","year":"2020","unstructured":"Garcia-Fabiani MB, Comba A, Kadiyala P, Haase S, N\u00fa\u00f1ez FJ, Altshuler D, et al. Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system. Methods Enzymol. 2020;632:369\u201388.","journal-title":"Methods Enzymol"},{"key":"3533_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1593\/tlo.09100","volume":"2","author":"D Hambardzumyan","year":"2009","unstructured":"Hambardzumyan D, Amankulor NM, Helmy KY, Becher OJ, Holland EC. Modeling Adult Gliomas Using RCAS\/t-va Technology. Transl Oncol. 2009;2:89\u201395.","journal-title":"Transl Oncol"},{"key":"3533_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ccell.2018.11.015","volume":"35","author":"JD Larson","year":"2019","unstructured":"Larson JD, Kasper LH, Paugh BS, Jin H, Wu G, Kwon CH, et al. Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression. Cancer Cell. 2019;35:140\u2013155.e147.","journal-title":"Cancer Cell"},{"key":"3533_CR24","doi-asserted-by":"crossref","unstructured":"Katagi H, Louis N, Unruh D, Sasaki T, He X, Zhang A, et al. Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma. Clinical Cancer Res. 2019;15:5572\u201383.","DOI":"10.1158\/1078-0432.CCR-18-3890"},{"key":"3533_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10043-0","volume":"10","author":"N Martinez-Velez","year":"2019","unstructured":"Martinez-Velez N, Garcia-Moure M, Marigil M, Gonzalez-Huarriz M, Puigdelloses M, Gallego Perez-Larraya J, et al. The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models. Nature Commun. 2019;10:2235.","journal-title":"Nature Commun"},{"key":"3533_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","volume":"24","author":"CW Mount","year":"2018","unstructured":"Mount CW, Majzner RG, Sundaresh S, Arnold EP, Kadapakkam M, Haile S, et al. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M(+) diffuse midline gliomas. Nature Med. 2018;24:572\u20139.","journal-title":"Nature Med"},{"key":"3533_CR27","doi-asserted-by":"crossref","unstructured":"Tsvankin V, Hashizume R, Katagi H, Herndon JE, Lascola C, Venkatraman TN et al. ABC Transporter inhibition plus dexamethasone enhances the efficacy of convection enhanced delivery in H3.3K27M mutant diffuse intrinsic pontine glioma. Neurosurgery 2019.","DOI":"10.1093\/neuros\/nyz212"},{"key":"3533_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.yexcr.2017.09.032","volume":"360","author":"MH Meel","year":"2017","unstructured":"Meel MH, Sewing ACP, Waranecki P, Metselaar DS, Wedekind LE, Koster J, et al. Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies. Exp cell Res. 2017;360:397\u2013403.","journal-title":"Exp cell Res"},{"key":"3533_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52096-w","volume":"15","author":"AF Andrade","year":"2024","unstructured":"Andrade AF, Annett A, Karimi E, Topouza DG, Rezanejad M, Liu Y, et al. Immune landscape of oncohistone-mutant gliomas reveals diverse myeloid populations and tumor-promoting function. Nature Commun. 2024;15:7769.","journal-title":"Nature Commun"},{"key":"3533_CR30","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41588-022-01236-3","volume":"54","author":"I Liu","year":"2022","unstructured":"Liu I, Jiang L, Samuelsson ER, Marco Salas S, Beck A, Hack OA, et al. The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location. Nat Genet. 2022;54:1881\u201394.","journal-title":"Nat Genet"},{"key":"3533_CR31","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1016\/j.immuni.2024.09.007","volume":"57","author":"JL Ross","year":"2024","unstructured":"Ross JL, Puigdelloses-Vallcorba M, Pi\u00f1ero G, Soni N, Thomason W, DeSisto J, et al. Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations. Immunity. 2024;57:2669\u20132687.e2666.","journal-title":"Immunity"},{"key":"3533_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA, et al. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nature Med. 2015;21:555\u20139.","journal-title":"Nature Med"},{"key":"3533_CR33","first-page":"5396","volume":"58","author":"N Keshelava","year":"1998","unstructured":"Keshelava N, Seeger RC, Groshen S, Reynolds CP. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy. Cancer Res. 1998;58:5396\u2013405.","journal-title":"Cancer Res"},{"key":"3533_CR34","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00262-015-1663-y","volume":"64","author":"M Kroesen","year":"2015","unstructured":"Kroesen M, Brok IC, Reijnen D, van Hout-Kuijer MA, Zeelenberg IS, Den Brok MH, et al. Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalents. Cancer Immunol Immunother. 2015;64:563\u201372.","journal-title":"Cancer Immunol Immunother"},{"key":"3533_CR35","doi-asserted-by":"crossref","unstructured":"Lin GL, Monje M. A protocol for rapid post-mortem cell culture of diffuse intrinsic pontine glioma (DIPG). J Vis Exp. 2017;121:55360.","DOI":"10.3791\/55360-v"},{"key":"3533_CR36","doi-asserted-by":"publisher","first-page":"25625","DOI":"10.1021\/acsomega.0c02564","volume":"5","author":"S Graw","year":"2020","unstructured":"Graw S, Tang J, Zafar MK, Byrd AK, Bolden C, Peterson EC, et al. proteiNorm - A User-Friendly Tool for Normalization and Analysis of TMT and Label-Free Protein Quantification. ACS Omega. 2020;5:25625\u201333.","journal-title":"ACS Omega"},{"key":"3533_CR37","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"3533_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"3533_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"3533_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 2010;11:R25.","journal-title":"Genome Biol"},{"key":"3533_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02949-2","volume":"24","author":"Y You","year":"2023","unstructured":"You Y, Dong X, Wee YK, Maxwell MJ, Alhamdoosh M, Smyth GK, et al. Modeling group heteroscedasticity in single-cell RNA-seq pseudo-bulk data. Genome Biol. 2023;24:107.","journal-title":"Genome Biol"},{"key":"3533_CR42","unstructured":"De Vries A, Ripley BD, de Vries MA. Package \u2018ggdendro\u20192022."},{"key":"3533_CR43","unstructured":"Warnes MGR, Bolker B, Bonebakker L, Gentleman R, Huber W. Package \u2018gplots\u2019. Various R programming tools for plotting data 2016."},{"key":"3533_CR44","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/bioinformatics\/btl567","volume":"23","author":"S Falcon","year":"2007","unstructured":"Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics. 2007;23:257\u20138.","journal-title":"Bioinformatics"},{"key":"3533_CR45","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u2013D612.","journal-title":"Nucleic Acids Res"},{"key":"3533_CR46","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"3533_CR47","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/1078-0432.CCR-03-0807","volume":"10","author":"S Ostermann","year":"2004","unstructured":"Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA, et al. Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clinical Cancer Res. 2004;10:3728\u201336.","journal-title":"Clinical Cancer Res"},{"key":"3533_CR48","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1016\/j.ejca.2013.08.006","volume":"49","author":"S Bailey","year":"2013","unstructured":"Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B, et al. Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy-results of a United Kingdom phase II trial (CNS 2007 04). Eur J Cancer. 2013;49:3856\u201362.","journal-title":"Eur J Cancer"},{"key":"3533_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24168-8","volume":"12","author":"C He","year":"2021","unstructured":"He C, Xu K, Zhu X, Dunphy PS, Gudenas B, Lin W, et al. Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma. Nature Commun. 2021;12:4089.","journal-title":"Nature Commun"},{"key":"3533_CR50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1674-8301(10)60057-7","volume":"24","author":"B Cui","year":"2010","unstructured":"Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS. Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells. J Biomed Res. 2010;24:424\u201335.","journal-title":"J Biomed Res"},{"key":"3533_CR51","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00280-021-04313-2","volume":"88","author":"MJ Homan","year":"2021","unstructured":"Homan MJ, Franson A, Ravi K, Roberts H, Pai MP, Liu C, et al. Panobinostat penetrates the blood-brain barrier and achieves effective brain concentrations in a murine model. Cancer Chemother Pharm. 2021;88:555\u201362.","journal-title":"Cancer Chemother Pharm"},{"key":"3533_CR52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/neuonc\/noaa249","volume":"23","author":"NA Vitanza","year":"2021","unstructured":"Vitanza NA, Biery MC, Myers C, Ferguson E, Zheng Y, Girard EJ, et al. Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-na\u00efve diffuse midline glioma models. Neuro-Oncol. 2021;23:376\u201386.","journal-title":"Neuro-Oncol"},{"key":"3533_CR53","doi-asserted-by":"crossref","unstructured":"Lin GL, Wilson KM, Ceribelli M, Stanton BZ, Woo PJ, Kreimer S, et al. Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening. Sci Transl Med. 2019;11:519.","DOI":"10.1126\/scitranslmed.aaw0064"},{"key":"3533_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000529099","volume":"58","author":"C Dalle Ore","year":"2023","unstructured":"Dalle Ore C, Coleman C, Gupta N, Mueller S. Advances and clinical trials update in the treatment of diffuse intrinsic pontine gliomas. Pediatric Neurosurg. 2023;58:259\u201366.","journal-title":"Pediatric Neurosurg"},{"key":"3533_CR55","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114283","volume":"14","author":"Z Baumann","year":"2022","unstructured":"Baumann Z, Auf der Maur P, Bentires-Alj M. Feed-forward loops between metastatic cancer cells and their microenvironment-the stage of escalation. EMBO Mol Med. 2022;14:e14283.","journal-title":"EMBO Mol Med"},{"key":"3533_CR56","doi-asserted-by":"crossref","unstructured":"Jayaram MA, Phillips JJ. Role of the microenvironment in glioma pathogenesis. Annu Rev Pathol. 2024;19:181\u2013201.","DOI":"10.1146\/annurev-pathmechdis-051122-110348"},{"key":"3533_CR57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11060-009-9954-9","volume":"96","author":"R Hashizume","year":"2010","unstructured":"Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, et al. A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neuro-Oncol. 2010;96:151\u20139.","journal-title":"J Neuro-Oncol"},{"key":"3533_CR58","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1101657108","volume":"108","author":"M Monje","year":"2011","unstructured":"Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, et al. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci USA. 2011;108:4453\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3533_CR59","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijpharm.2018.09.040","volume":"551","author":"C Puech","year":"2018","unstructured":"Puech C, Hodin S, Forest V, He Z, Mismetti P, Delavenne X, et al. Assessment of HBEC-5i endothelial cell line cultivated in astrocyte conditioned medium as a human blood-brain barrier model for ABC drug transport studies. Int J Pharm. 2018;551:281\u20139.","journal-title":"Int J Pharm"},{"key":"3533_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1288-0","volume":"15","author":"C Dello Russo","year":"2018","unstructured":"Dello Russo C, Cappoli N, Coletta I, Mezzogori D, Paciello F, Pozzoli G, et al. The human microglial HMC3 cell line: where do we stand? A systematic literature review. J Neuroinf. 2018;15:259.","journal-title":"J Neuroinf"},{"key":"3533_CR61","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.nano.2015.07.013","volume":"11","author":"P Sethi","year":"2015","unstructured":"Sethi P, Jyoti A, Swindell EP, Chan R, Langner UW, Feddock JM, et al. 3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation. Nanomedicine. 2015;11:2013\u201323.","journal-title":"Nanomedicine"},{"key":"3533_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4939-7401-6_11","volume":"1692","author":"M Upreti","year":"2018","unstructured":"Upreti M. Tumor tissue analogs for the assessment of radioresistance in cancer stem cells. Methods Mol Biol. 2018;1692:117\u201328.","journal-title":"Methods Mol Biol"},{"key":"3533_CR63","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.ccell.2023.09.001","volume":"41","author":"I Ausejo-Mauleon","year":"2023","unstructured":"Ausejo-Mauleon I, Labiano S, de la Nava D, Laspidea V, Zalacain M, Marrod\u00e1n L, et al. TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory. Cancer Cell. 2023;41:1911\u20131926.e1918.","journal-title":"Cancer Cell"},{"key":"3533_CR64","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40478-025-01952-x","volume":"13","author":"A Kordowski","year":"2025","unstructured":"Kordowski A, Mulay O, Tan X, Vo T, Baumgartner U, Maybury MK, et al. Spatial analysis of a complete DIPG-infiltrated brainstem reveals novel ligand-receptor mediators of tumour-to-TME crosstalk. Acta Neuropathol Commun. 2025;13:35.","journal-title":"Acta Neuropathol Commun"},{"key":"3533_CR65","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-019-03287-9","volume":"145","author":"FE El-Khouly","year":"2019","unstructured":"El-Khouly FE, Veldhuijzen van Zanten SEM, Santa-Maria Lopez V, Hendrikse NH, Kaspers GJL, Loizos G, et al. Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?. J Neuro-Oncol. 2019;145:177\u201384.","journal-title":"J Neuro-Oncol"},{"key":"3533_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab169","volume":"3","author":"RJ Duchatel","year":"2021","unstructured":"Duchatel RJ, Mannan A, Woldu AS, Hawtrey T, Hindley PA, Douglas AM, et al. Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma. Neuro-Oncol Adv. 2021;3:vdab169.","journal-title":"Neuro-Oncol Adv"},{"key":"3533_CR67","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ccell.2017.03.011","volume":"31","author":"S Nagaraja","year":"2017","unstructured":"Nagaraja S, Vitanza NA, Woo PJ, Taylor KR, Liu F, Zhang L, et al. Transcriptional dependencies in diffuse intrinsic pontine glioma. Cancer Cell. 2017;31:635\u2013652.e636.","journal-title":"Cancer Cell"},{"key":"3533_CR68","first-page":"Cd007415","volume":"2013","author":"MG Hart","year":"2013","unstructured":"Hart MG, Garside R, Rogers G, Stein K, Grant R. Temozolomide for high grade glioma. Cochrane Database Syst Rev. 2013;2013:Cd007415.","journal-title":"Cochrane Database Syst Rev"},{"key":"3533_CR69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1179\/1973947814Y.0000000228","volume":"27","author":"D Rizzo","year":"2015","unstructured":"Rizzo D, Scalzone M, Ruggiero A, Maurizi P, Attin\u00e0 G, Mastrangelo S, et al. Temozolomide in the treatment of newly diagnosed diffuse brainstem glioma in children: a broken promise?. J Chemother. 2015;27:106\u201310.","journal-title":"J Chemother"},{"key":"3533_CR70","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00381-014-2359-x","volume":"30","author":"SG Vallero","year":"2014","unstructured":"Vallero SG, Bertin D, Basso ME, Pittana LS, Mussano A, Fagioli F. Diffuse intrinsic pontine glioma in children and adolescents: a single-center experience. Child\u2019s Nerv Syst ChNS. 2014;30:1061\u20136.","journal-title":"Child\u2019s Nerv Syst ChNS"},{"key":"3533_CR71","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3389\/fonc.2019.01568","volume":"9","author":"H Abe","year":"2019","unstructured":"Abe H, Natsumeda M, Okada M, Watanabe J, Tsukamoto Y, Kanemaru Y, et al. MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline Gliomas. Frontiers Oncol. 2019;9:1568.","journal-title":"Frontiers Oncol"},{"key":"3533_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08579-w","volume":"21","author":"AC Harttrampf","year":"2021","unstructured":"Harttrampf AC, da Costa MEM, Renoult A, Daudigeos-Dubus E, Geoerger B. Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation. BMC Cancer. 2021;21:833.","journal-title":"BMC Cancer"},{"key":"3533_CR73","doi-asserted-by":"publisher","first-page":"e0169407","DOI":"10.1371\/journal.pone.0169407","volume":"12","author":"AN Laporte","year":"2017","unstructured":"Laporte AN, Barrott JJ, Yao RJ, Poulin NM, Brodin BA, Jones KB, et al. HDAC and proteasome inhibitors synergize to activate pro-apoptotic factors in synovial sarcoma. PLoS One. 2017;12:e0169407.","journal-title":"PLoS One"},{"key":"3533_CR74","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab142","volume":"3","author":"DA Bota","year":"2021","unstructured":"Bota DA, Mason W, Kesari S, Magge R, Winograd B, Elias I, et al. Marizomib alone or in combination with bevacizumab in patients with recurrent glioblastoma: Phase I\/II clinical trial data. Neuro-Oncol Adv. 2021;3:vdab142.","journal-title":"Neuro-Oncol Adv"},{"key":"3533_CR75","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/neuonc\/nou350","volume":"17","author":"EQ Lee","year":"2015","unstructured":"Lee EQ, Reardon DA, Schiff D, Drappatz J, Muzikansky A, Grimm SA, et al. Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma. Neuro-Oncol. 2015;17:862\u20137.","journal-title":"Neuro-Oncol"},{"key":"3533_CR76","doi-asserted-by":"crossref","unstructured":"Cupit-Link M, Federico SM. Treatment of high-risk neuroblastoma with dinutuximab and chemotherapy administered in all cycles of induction. Cancers 2023;15:4609.","DOI":"10.3390\/cancers15184609"},{"key":"3533_CR77","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1053\/j.seminoncol.2015.05.012","volume":"42","author":"JL Goldberg","year":"2015","unstructured":"Goldberg JL, Sondel PM. Enhancing Cancer Immunotherapy Via Activation of Innate Immunity. Semin Oncol. 2015;42:562\u201372.","journal-title":"Semin Oncol"},{"key":"3533_CR78","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1182\/blood-2015-07-660506","volume":"128","author":"M Xiang","year":"2016","unstructured":"Xiang M, Kim H, Ho VT, Walker SR, Bar-Natan M, Anahtar M, et al. Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent. Blood. 2016;128:1845\u201353.","journal-title":"Blood"},{"key":"3533_CR79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fonc.2019.00135","volume":"9","author":"F Barbieri","year":"2019","unstructured":"Barbieri F, Verduci I, Carlini V, Zona G, Pagano A, Mazzanti M, et al. Repurposed biguanide drugs in glioblastoma exert antiproliferative effects via the inhibition of intracellular chloride channel 1 Activity. Frontiers Oncol. 2019;9:135.","journal-title":"Frontiers Oncol"},{"key":"3533_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01258-7","volume":"19","author":"S Zou","year":"2020","unstructured":"Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X. Targeting STAT3 in Cancer Immunotherapy. Mol Cancer. 2020;19:145.","journal-title":"Mol Cancer"},{"key":"3533_CR81","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1021\/acs.jmedchem.2c00660","volume":"65","author":"FR Zetterberg","year":"2022","unstructured":"Zetterberg FR, MacKinnon A, Brimert T, Gravelle L, Johnsson RE, Kahl-Knutson B, et al. Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease. J Med Chem. 2022;65:12626\u201338.","journal-title":"J Med Chem"},{"key":"3533_CR82","doi-asserted-by":"crossref","unstructured":"de la Nava D, Ausejo-Mauleon I, Laspidea V, Gonzalez-Huarriz M, Lacalle A, Casares N, et al. The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models. Neuro-oncology 2024;5:1509\u201325.","DOI":"10.1093\/neuonc\/noae066"},{"key":"3533_CR83","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.actbio.2020.09.007","volume":"116","author":"C Wang","year":"2020","unstructured":"Wang C, Sinha S, Jiang X, Fitch S, Wilson C, Caretti V, et al. A comparative study of brain tumor cells from different age and anatomical locations using 3D biomimetic hydrogels. Acta Biomater. 2020;116:201\u20138.","journal-title":"Acta Biomater"},{"key":"3533_CR84","doi-asserted-by":"crossref","unstructured":"Khamis ZI, Sarker DB, Xue Y, Al-Akkary N, James VD, Zeng C et al. Modeling human brain tumors and the microenvironment using induced pluripotent stem cells. Cancers 2023;15:1253.","DOI":"10.3390\/cancers15041253"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03533-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03533-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T22:03:33Z","timestamp":1758578613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-025-03533-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":84,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2025,10,14]]}},"alternative-id":["3533"],"URL":"https:\/\/doi.org\/10.1038\/s41388-025-03533-7","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"(a)The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (b) All research activities undertaken were conducted in accordance with strict ethical principles and in compliance with regulations and policies that were reviewed and duly approved by the CHLA Regulatory Oversight Committees, Institutional Biosafety Committee (IBC-20-003 and IBC-24-008) and Institutional Review Board (CHLA-21-00319). (c) Informed consent was obtained from all participants for collecting the blood samples and processed in accordance with an institutional review board approved protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}